melatonin has been researched along with Retinopathy of Prematurity in 6 studies
Retinopathy of Prematurity: A bilateral retinopathy occurring in premature infants treated with excessively high concentrations of oxygen, characterized by vascular dilatation, proliferation, and tortuosity, edema, and retinal detachment, with ultimate conversion of the retina into a fibrous mass that can be seen as a dense retrolental membrane. Usually growth of the eye is arrested and may result in microophthalmia, and blindness may occur. (Dorland, 27th ed)
Excerpt | Relevance | Reference |
---|---|---|
" All preterm neonates with gestational age (GA) < 34 weeks or birth weight (BW) < 2000 grams eligible for ROP screening were randomized into oral melatonin (4 mg/kg) and oral 24% sucrose (0." | 9.51 | Comparison between oral melatonin and 24% sucrose for pain management during retinopathy of prematurity screening: a randomized controlled trial. ( Behura, SS; Dhanawat, A; Nayak, B; Panda, SK, 2022) |
"Retinopathy of prematurity is a vision-threatening disease associated with retinal hypoxia-ischemia, leading to the death of retinal neurons and chronic neuronal degeneration." | 5.62 | Melatonin protects inner retinal neurons of newborn mice after hypoxia-ischemia. ( Cui, K; Huang, R; Liang, X; Lin, J; Liu, Y; Lu, X; Shi, Y; Tang, X; Xu, Y; Ye, D; Yu, S, 2021) |
" All preterm neonates with gestational age (GA) < 34 weeks or birth weight (BW) < 2000 grams eligible for ROP screening were randomized into oral melatonin (4 mg/kg) and oral 24% sucrose (0." | 5.51 | Comparison between oral melatonin and 24% sucrose for pain management during retinopathy of prematurity screening: a randomized controlled trial. ( Behura, SS; Dhanawat, A; Nayak, B; Panda, SK, 2022) |
"Urinary melatonin concentration below the certain cut-off values in the early neonatal period may serve as one of the predictors of adverse outcomes such as BPD, ROP, and late-onset sepsis in the late neonatal period in preterm infants." | 4.31 | The relationship of melatonin concentration in preterm infants and adverse outcomes in the late neonatal period. ( Kozak, K; Pavlyshyn, Н; Sarapuk, I, 2023) |
"Intraperitoneal injections of exogenous melatonin during the development of the retinal vascular system in experimental rats has been shown in a number of experimental studies on the model of EROP to prevent the appearance of histological signs of the development of experimental retinopathy of prematurity (EROP), stabilize the blood-retinal barrier and have a pronounced antioxidant effect, but pathogenetic basis for these phenomena hasn't been studied." | 4.02 | [Pathogenetically oriented approach to prevention of retinopathy of prematurity (experimental study)]. ( Beznos, OV; Chesnokova, NB; Katargina, LA; Osipova, NA; Panova, AY, 2021) |
"Retinopathy of prematurity is a vision-threatening disease associated with retinal hypoxia-ischemia, leading to the death of retinal neurons and chronic neuronal degeneration." | 1.62 | Melatonin protects inner retinal neurons of newborn mice after hypoxia-ischemia. ( Cui, K; Huang, R; Liang, X; Lin, J; Liu, Y; Lu, X; Shi, Y; Tang, X; Xu, Y; Ye, D; Yu, S, 2021) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 4 (66.67) | 2.80 |
Authors | Studies |
---|---|
Behura, SS | 1 |
Dhanawat, A | 1 |
Nayak, B | 1 |
Panda, SK | 1 |
Pavlyshyn, Н | 1 |
Sarapuk, I | 1 |
Kozak, K | 1 |
Huang, R | 1 |
Xu, Y | 2 |
Lu, X | 2 |
Tang, X | 1 |
Lin, J | 1 |
Cui, K | 1 |
Yu, S | 2 |
Shi, Y | 1 |
Ye, D | 1 |
Liu, Y | 1 |
Liang, X | 2 |
Katargina, LA | 1 |
Chesnokova, NB | 1 |
Beznos, OV | 1 |
Osipova, NA | 1 |
Panova, AY | 1 |
Hu, Y | 1 |
Yang, B | 1 |
Tsui, CK | 1 |
Lu, L | 1 |
Yzydorczyk, C | 1 |
Mitanchez, D | 1 |
Buffat, C | 1 |
Ligi, I | 1 |
Grandvuillemin, I | 1 |
Boubred, F | 1 |
Simeoni, U | 1 |
1 review available for melatonin and Retinopathy of Prematurity
Article | Year |
---|---|
[Oxidative stress after preterm birth: origins, biomarkers, and possible therapeutic approaches].
Topics: Advanced Oxidation Protein Products; Aldehydes; Antioxidants; Biomarkers; Breast Feeding; Delivery R | 2015 |
1 trial available for melatonin and Retinopathy of Prematurity
Article | Year |
---|---|
Comparison between oral melatonin and 24% sucrose for pain management during retinopathy of prematurity screening: a randomized controlled trial.
Topics: Birth Weight; Humans; Infant; Infant, Newborn; Melatonin; Pain; Pain Management; Pain Measurement; P | 2022 |
4 other studies available for melatonin and Retinopathy of Prematurity
Article | Year |
---|---|
The relationship of melatonin concentration in preterm infants and adverse outcomes in the late neonatal period.
Topics: Bronchopulmonary Dysplasia; Humans; Infant; Infant, Newborn; Infant, Premature; Melatonin; Retinopat | 2023 |
Melatonin protects inner retinal neurons of newborn mice after hypoxia-ischemia.
Topics: Animals; Animals, Newborn; Hypoxia; Ischemia; Melatonin; Mice; Mice, Inbred C57BL; Neuroprotective A | 2021 |
[Pathogenetically oriented approach to prevention of retinopathy of prematurity (experimental study)].
Topics: Animals; Animals, Newborn; Disease Models, Animal; Humans; Infant, Newborn; Melatonin; Rats; Rats, W | 2021 |
Melatonin attenuated retinal neovascularization and neuroglial dysfunction by inhibition of HIF-1α-VEGF pathway in oxygen-induced retinopathy mice.
Topics: Animals; Hypoxia-Inducible Factor 1, alpha Subunit; Melatonin; Mice; Mice, Inbred C57BL; Neuroglia; | 2018 |